NEW YORK (GenomeWeb) – Affymetrix reported after the close of the market Wednesday that its fourth quarter revenues increased 2 percent year over year, beating the consensus Wall Street estimate.

The Santa Clara, California-based microarray and genetic analysis products firm reported total revenues of $95.6 million for the quarter ended Dec. 31, 2015, up from $93.5 million in Q4 2014 and beating analysts' consensus estimate of $93.3 million. On a constant currency basis, Affy said its Q4 2015 revenues were up nearly 7 percent year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.

Sponsored by

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.